Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
D003913 |
Dextroamphetamine |
Dextroamphetamine results in increased expression of EPRS mRNA | increases expression | 12558987
|
D015123 |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of EPRS mRNA | decreases expression | 19150397 20018196
|
C006780 |
bisphenol A |
bisphenol A results in decreased expression of EPRS mRNA | decreases expression | 20678512
|
D016572 |
Cyclosporine |
Cyclosporine results in increased expression of EPRS mRNA | increases expression | 20106945
|
D005472 |
Fluorouracil |
Fluorouracil results in decreased expression of EPRS mRNA | decreases expression | 16709241
|
D006830 |
Hydralazine |
[Hydralazine co-treated with Valproic Acid] results in increased expression of EPRS mRNA | affects cotreatment|increases expression | 17183730
|
D008727 |
Methotrexate |
EPRS protein affects the susceptibility to Methotrexate | affects response to substance | 16217747
|
C004648 |
testosterone enanthate |
testosterone enanthate affects the expression of EPRS mRNA | affects expression | 17440010
|
D014635 |
Valproic Acid |
[Hydralazine co-treated with Valproic Acid] results in increased expression of EPRS mRNA | affects cotreatment|increases expression | 17183730
|
C025643 |
vinclozolin |
vinclozolin affects the expression of EPRS mRNA | affects expression | 19015723
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Methotrexate |
9.63 | 12039119 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Valproic Acid |
9.63 | 8875741 |
MESH:D000015 |
Abnormalities, Multiple |
|
Valproic Acid |
4.10 | 19490988 |
MESH:D000230 |
Adenocarcinoma |
|
Fluorouracil |
2.46 | 17638652 |
MESH:D000550 |
Amblyopia |
|
Valproic Acid |
5.50 | 17688650 |
MESH:D000740 |
Anemia |
|
Fluorouracil |
3.87 | 15504547 17963324 16511603 |
MESH:D001008 |
Anxiety Disorders |
|
Valproic Acid |
9.32 | 17497229 |
MESH:D001008 |
Anxiety Disorders |
|
vinclozolin |
9.32 | 19015723 |
MESH:D001172 |
Arthritis, Rheumatoid |
|
Methotrexate |
3.13 | 17286800 |
MESH:D001321 |
Autistic Disorder |
|
Valproic Acid |
1.99 | 17688650 18316065 18177632 18985861 18775368 18940202 16609825 20603192 19460635 18558336 19232924 17507914 17157402 18396377 15238991 |
MESH:D001714 |
Bipolar Disorder |
|
Valproic Acid |
3.15 | 17594078 20046352 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Valproic Acid |
3.51 | 8888407 |
MESH:D001862 |
Bone Resorption |
|
bisphenol A |
4.03 | 11985600 |
MESH:D001943 |
Breast Neoplasms |
|
bisphenol A |
2.08 | 17123778 |
MESH:D001943 |
Breast Neoplasms |
|
Fluorouracil |
2.08 | 16557594 15136595 16110121 19217205 18357371 18608205 16595493 |
MESH:D001943 |
Breast Neoplasms |
|
Methotrexate |
2.08 | 16978400 |
MESH:D002276 |
Carcinoid Tumor |
|
Fluorouracil |
4.93 | 16051944 |
MESH:D002277 |
Carcinoma |
|
Fluorouracil |
3.70 | 17121937 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Fluorouracil |
2.10 | 17045692 17088986 16799960 18930000 16332177 17971768 |
MESH:D002278 |
Carcinoma in Situ |
|
bisphenol A |
5.23 | 17123778 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
Fluorouracil |
3.09 | 18695887 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Fluorouracil |
2.53 | 17066447 16757204 18986760 16280240 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
6.94 | 20889678 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Cyclosporine |
6.94 | 12371664 |
MESH:D002659 |
Child Development Disorders, Pervasive |
|
Valproic Acid |
2.76 | 20734317 |
MESH:D002779 |
Cholestasis |
|
Cyclosporine |
3.04 | 19486331 |
MESH:D003110 |
Colonic Neoplasms |
|
Fluorouracil |
2.26 | 15001691 17018589 16510598 16340194 17725105 17172411 17016597 17287894 18772588 17169374 |
MESH:D015179 |
Colorectal Neoplasms |
|
Fluorouracil |
2.00 | 17594712 17401013 15289873 20501625 18448328 16303861 17094418 15148649 16282729 16524972 18288408 18509181 16391804 17454858 17016601 18383874 18949393 18802399 17255274 17695437 14970324 16331619 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Methotrexate |
3.03 | 9562676 12039119 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Valproic Acid |
3.03 | 8888407 16575769 17688650 |
MESH:D003456 |
Cryptorchidism |
|
vinclozolin |
4.54 | 14966744 |
MESH:D003550 |
Cystic Fibrosis |
|
Methotrexate |
4.40 | 19747007 |
MESH:D007644 |
Darier Disease |
|
Fluorouracil |
5.03 | 16733453 |
MESH:D003882 |
Dermatomyositis |
|
Methotrexate |
5.32 | 20191521 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Valproic Acid |
2.21 | 19641884 1733752 |
MESH:D004421 |
Dystonia |
|
Valproic Acid |
4.23 | 1851702 |
MESH:D004831 |
Epilepsies, Myoclonic |
|
Valproic Acid |
4.37 | 17275665 3659116 |
MESH:D004828 |
Epilepsies, Partial |
|
Valproic Acid |
4.18 | 3922381 16628512 |
MESH:D004827 |
Epilepsy |
|
Valproic Acid |
3.01 | 20417680 18234410 |
MESH:D004832 |
Epilepsy, Absence |
|
Valproic Acid |
3.74 | 7562514 6254150 6426943 |
MESH:D017029 |
Epilepsy, Complex Partial |
|
Valproic Acid |
4.51 | 7750514 |
MESH:D004830 |
Epilepsy, Tonic-Clonic |
|
Valproic Acid |
4.30 | 3659116 |
MESH:D004938 |
Esophageal Neoplasms |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
4.64 | 20426865 |
MESH:D004938 |
Esophageal Neoplasms |
|
Fluorouracil |
4.64 | 15173087 16481741 17638652 16337965 16785472 |
MESH:D005234 |
Fatty Liver |
|
Cyclosporine |
8.33 | 19224547 |
MESH:D005234 |
Fatty Liver |
|
Valproic Acid |
8.33 | 14986274 19224547 |
MESH:D005315 |
Fetal Diseases |
|
Valproic Acid |
5.15 | 16575769 |
MESH:D005317 |
Fetal Growth Retardation |
|
Valproic Acid |
4.33 | 8888407 18558336 |
MESH:D005355 |
Fibrosis |
|
Cyclosporine |
3.36 | 12639820 12168785 |
MESH:D030342 |
Genetic Diseases, Inborn |
|
vinclozolin |
5.17 | 16973722 |
MESH:D005832 |
Genital Diseases, Male |
|
vinclozolin |
5.57 | 16417039 |
MESH:D005885 |
Gingival Hyperplasia |
|
Cyclosporine |
4.46 | 8708960 |
MESH:D005910 |
Glioma |
|
Fluorouracil |
2.93 | 16145905 |
MESH:D006086 |
Graft vs Host Disease |
|
Methotrexate |
5.36 | 16518429 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Fluorouracil |
3.50 | 18337622 15102660 15162350 |
MESH:D006457 |
Hemoglobinuria, Paroxysmal |
|
Cyclosporine |
4.66 | 15720958 |
MESH:D019247 |
HIV Wasting Syndrome |
|
testosterone enanthate |
6.01 | 17440010 |
MESH:D006849 |
Hydrocephalus |
|
Valproic Acid |
5.10 | 17688650 |
MESH:D006973 |
Hypertension |
|
Cyclosporine |
2.15 | 10903974 |
MESH:D046110 |
Hypertension, Pregnancy-Induced |
|
Hydralazine |
4.84 | 16612254 |
MESH:D007248 |
Infertility, Male |
|
vinclozolin |
3.15 | 16467254 |
MESH:D007333 |
Insulin Resistance |
|
bisphenol A |
3.39 | 16393666 |
MESH:D007638 |
Keratoconjunctivitis Sicca |
|
Cyclosporine |
4.71 | 15604871 |
MESH:D007674 |
Kidney Diseases |
|
Cyclosporine |
2.43 | 8314463 18776723 10903974 |
MESH:D007680 |
Kidney Neoplasms |
|
Cyclosporine |
7.88 | 12371664 |
MESH:D007680 |
Kidney Neoplasms |
|
Fluorouracil |
7.88 | 16985049 |
MESH:D007805 |
Language Development Disorders |
|
Methotrexate |
5.29 | 9562676 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Valproic Acid |
2.17 | 17596541 16294345 |
MESH:D007984 |
Leydig Cell Tumor |
|
vinclozolin |
4.97 | 16417039 |
MESH:D008103 |
Liver Cirrhosis |
|
Methotrexate |
3.79 | 14986274 |
MESH:D008113 |
Liver Neoplasms |
|
Fluorouracil |
2.53 | 18383874 17045692 15113037 16603448 |
MESH:D017563 |
Lung Diseases, Interstitial |
|
Methotrexate |
12.37 | 18516814 |
MESH:D017563 |
Lung Diseases, Interstitial |
|
Valproic Acid |
12.37 | 17228818 |
MESH:D008175 |
Lung Neoplasms |
|
Fluorouracil |
2.00 | 15246190 |
MESH:D008178 |
Lupus Erythematosus, Cutaneous |
|
Fluorouracil |
5.03 | 15086387 |
MESH:D008223 |
Lymphoma |
|
Methotrexate |
4.07 | 17352296 |
MESH:D008664 |
Metal Metabolism, Inborn Errors |
|
Cyclosporine |
5.05 | 16801185 |
MESH:D008881 |
Migraine Disorders |
|
Valproic Acid |
3.31 | 18765137 18803445 |
MESH:D009041 |
Motion Sickness |
|
Dextroamphetamine |
5.79 | 1613127 |
MESH:D009062 |
Mouth Neoplasms |
|
Fluorouracil |
3.76 | 18986760 16757204 |
MESH:D052016 |
Mucositis |
|
Methotrexate |
5.52 | 17488658 |
MESH:D009139 |
Musculoskeletal Abnormalities |
|
Valproic Acid |
4.20 | 8888407 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
Valproic Acid |
3.24 | 17596541 |
MESH:D009369 |
Neoplasms |
|
Fluorouracil |
2.68 | 16928823 18600527 18239605 |
MESH:D009402 |
Nephrosis, Lipoid |
|
Cyclosporine |
4.71 | 17954296 |
MESH:D009404 |
Nephrotic Syndrome |
|
Cyclosporine |
3.44 | 19348381 18481113 |
MESH:D009421 |
Nervous System Malformations |
|
bisphenol A |
4.17 | 16427766 11399458 |
MESH:D009436 |
Neural Tube Defects |
|
Valproic Acid |
3.23 | 16359493 8888407 |
MESH:D020258 |
Neurotoxicity Syndromes |
|
Fluorouracil |
3.55 | 16436463 |
MESH:D010049 |
Ovarian Diseases |
|
bisphenol A |
5.23 | 11985600 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Fluorouracil |
2.72 | 16500647 19003803 15113037 16929163 |
MESH:D011230 |
Precancerous Conditions |
|
Cyclosporine |
3.37 | 12371664 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
bisphenol A |
17.79 | 10548101 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Valproic Acid |
17.79 | 20603192 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
vinclozolin |
17.79 | 18220299 18042343 19015723 |
MESH:D011469 |
Prostatic Diseases |
|
vinclozolin |
5.17 | 18220299 |
MESH:D019048 |
Prostatic Intraepithelial Neoplasia |
|
bisphenol A |
4.38 | 20887781 |
MESH:D011471 |
Prostatic Neoplasms |
|
bisphenol A |
3.35 | 16740699 |
MESH:D011471 |
Prostatic Neoplasms |
|
Fluorouracil |
3.35 | 19082440 18626508 |
MESH:D011472 |
Prostatitis |
|
vinclozolin |
5.17 | 18629315 |
MESH:D019310 |
Pseudolymphoma |
|
Valproic Acid |
4.81 | 11422049 12752131 |
MESH:D011565 |
Psoriasis |
|
Cyclosporine |
6.08 | 16882103 |
MESH:D011565 |
Psoriasis |
|
Methotrexate |
6.08 | 17410198 |
MESH:D011629 |
Puberty, Precocious |
|
bisphenol A |
5.02 | 10548101 |
MESH:D012004 |
Rectal Neoplasms |
|
Fluorouracil |
4.16 | 18286688 16160472 15538739 18722050 |
MESH:D051437 |
Renal Insufficiency |
|
Methotrexate |
4.93 | 17352296 |
MESH:D012208 |
Rhabdomyosarcoma |
|
Valproic Acid |
4.36 | 19155313 |
MESH:D012559 |
Schizophrenia |
|
Valproic Acid |
2.09 | 19110320 15737665 |
MESH:D012640 |
Seizures |
|
Valproic Acid |
2.85 | 15475178 11044598 16876388 3137016 17978042 14763951 11738929 1511512 |
MESH:D016135 |
Spinal Dysraphism |
|
Valproic Acid |
3.91 | 19490988 |
MESH:D013226 |
Status Epilepticus |
|
Valproic Acid |
4.81 | 12833885 |
MESH:D013274 |
Stomach Neoplasms |
|
Fluorouracil |
2.00 | 16424979 19015929 17522103 17172411 16951190 18396642 15786421 18567086 19084572 17498489 |
MESH:D019966 |
Substance-Related Disorders |
|
bisphenol A |
4.22 | 16684133 16045194 |
MESH:D013576 |
Syndactyly |
|
Methotrexate |
5.23 | 9562676 |
MESH:D014062 |
Tongue Neoplasms |
|
Fluorouracil |
4.15 | 16280240 |
MESH:D014178 |
Translocation, Genetic |
|
Valproic Acid |
5.50 | 17262798 |
MESH:D020194 |
Unverricht-Lundborg Syndrome |
|
Valproic Acid |
4.76 | 3119515 |
MESH:D014564 |
Urogenital Abnormalities |
|
Valproic Acid |
4.86 | 8888407 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
Fluorouracil |
4.04 | 16803524 |
MESH:D014591 |
Uterine Diseases |
|
bisphenol A |
5.27 | 14652134 |
MESH:D014605 |
Uveitis |
|
Cyclosporine |
4.25 | 1336536 |
MESH:D014985 |
Xerophthalmia |
|
Cyclosporine |
4.71 | 17120751 |